ArticleStatistics in medicine2026
ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mediation analysis is a fundamental tool for understanding biological mechanisms through which an exposure exerts its effect on an outcome via intermediate variables, or mediators. However, modern biomedical studies often involve multiple exposures and mediators with complex correlation structures, and may also involve multiple outcomes, as in multi-omics or imaging studies, where existing mediation analyses can suffer from instability and limited interpretability. In this work, we propose Envelope-Based Sparse Partial Least Squares for Mediation Analysis (ESPLSM), which integrates dimension reduction and sparsity enforcement via the sparse envelope model to improve estimation and interpretation of causal effects. We embed the envelope model within the causal mediation framework based on potential outcomes, which allows us to formally define and identify direct and indirect effects and to establish theoretical guarantees, including asymptotic efficiency and selection consistency. Through simulation studies, we show that ESPLSM outperforms existing methods in terms of estimation accuracy, statistical power, and variable selection. Finally, we apply ESPLSM to a cancer cell line dataset to investigate the role of RNA expression in mediating the effect of EGFR mutations on drug responses. Our results provide new insights into the molecular mechanisms underlying targeted cancer therapies. Overall, ESPLSM provides a statistically principled yet practical solution for interpretable and efficient mediation analysis in modern high-dimensional biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.